Paper50513
Nomogram for derivation of renal threshold phosphate concentration.
Walton RJ and 1 other. Lancet, 1975. Cited by 813 papers, by iCite.
Cite this record
ConductScience Library. Nomogram for derivation of renal threshold phosphate concentration. Papers, record 50513. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/50513
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney | Major topic |
| Phosphates | Major topic |
| Absorption | |
| Creatinine | |
| Glomerular Filtration Rate | |
| Humans | |
| Kidney Tubules | |
| Mathematics | |
| Metabolic Clearance Rate | |
| Weights and Measures |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02233322 | Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project. | Background |
Source ClinicalTrials.gov
Cited by210
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 813 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42568369 | Unveiling the biochemical signature of tumor-induced osteomalacia: implications for distinguishing it from primary osteoporosis. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/42568369 | PubMed |
| 42445141 | Hypophosphatemia-factors associated with its development and 90-day mortality effect: a prospective observational study. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42445141 | PubMed |
| 42415082 | Clinical characteristics of tumor-induced osteomalacia lesions in the neurocranium and intracranial structures. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/42415082 | PubMed |
| 42273000 | Burosumab for X-linked Hypophosphataemia and Tumour-induced Osteomalacia in Adults. | touchREV Endocrinol | 2026 | https://conductscience.org/library/papers/42273000 | PubMed |
| 41938297 | Two Cases of Iron-Induced Hypophosphatemia. | AACE Endocrinol Diabetes | 2026 | https://conductscience.org/library/papers/41938297 | PubMed |
| 41918597 | Approach to Renal Tubular Acidosis - A Review. | Indian J Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41918597 | PubMed |
| 41501877 | Burosumab in infants with X-linked hypophosphatemic rickets: a case series. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/41501877 | PubMed |
| 41445558 | Harmonized Tubular Maximum Phosphate reabsorption per Glomerular Filtration Rate reporting in adults and children in Australia and New Zealand. | JBMR Plus | 2025 | https://conductscience.org/library/papers/41445558 | PubMed |
| 41445556 | A case and review of fibroblast growth factor-23-mediated hypophosphatemic osteomalacia in the absence of pathogenic PHEX variants. | JBMR Plus | 2025 | https://conductscience.org/library/papers/41445556 | PubMed |
| 41370665 | Supplements for bone health. | Arch Endocrinol Metab | 2025 | https://conductscience.org/library/papers/41370665 | PubMed |
| 41228426 | Metabolic Disruption in Osteoporotic Sheep: Evaluating Vitamin D Deficiency and Cortisone Effects via Biochemical Markers. | Nutrients | 2025 | https://conductscience.org/library/papers/41228426 | PubMed |
| 40965554 | A nomogram for predicting surgery outcome of tumor-induced osteomalacia: a case-control study. | Osteoporos Int | 2025 | https://conductscience.org/library/papers/40965554 | PubMed |
| 40917322 | Clinical Profile and Treatment Outcomes of Tumour-Induced Osteomalacia - A Single-Centre Experience. | Indian J Endocrinol Metab | 2025 | https://conductscience.org/library/papers/40917322 | PubMed |
| 40591205 | Experts' consensus on the management and treatment of individuals with X-linked hypophosphatemia across lifespan. | J Endocrinol Invest | 2025 | https://conductscience.org/library/papers/40591205 | PubMed |
| 40295317 | The Diagnosis and Therapy of XLH. | Calcif Tissue Int | 2025 | https://conductscience.org/library/papers/40295317 | PubMed |
| 39934509 | Phosphate metabolism in primary hyperparathyroidism: a real-life long-term study. | Endocrine | 2025 | https://conductscience.org/library/papers/39934509 | PubMed |
| 39808531 | Metabolic consequences and tubular function after augmentation cystoplasty in children with neurogenic bladder. | J Chin Med Assoc | 2025 | https://conductscience.org/library/papers/39808531 | PubMed |
| 39506343 | Diagnostic approach to rickets: an Endocrine Society of Bengal (ESB) consensus statement. | Ann Pediatr Endocrinol Metab | 2024 | https://conductscience.org/library/papers/39506343 | PubMed |
| 39267507 | [Clinical value of renal phosphorus threshold in the diagnosis and treatment X-linked hypophosphatemic rickets in children]. | Zhongguo Dang Dai Er Ke Za Zhi | 2024 | https://conductscience.org/library/papers/39267507 | PubMed |
| 39093437 | Clinical characteristics and surgical outcomes of vertebral lesions associated with tumor-induced osteomalacia: report of 16 patients and review of the literature. | Osteoporos Int | 2024 | https://conductscience.org/library/papers/39093437 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/50513
GET https://conductscience.org/api/papers/v1/50513/cited_by?page=2